Clinical Trial Update: Oral Vinorelbine in Combination With Trastuzumab for Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

This clinical trial update indicates the completion of a Phase 2 study evaluating oral vinorelbine in combination with trastuzumab for metastatic breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• HERCEPTIN (trastuzumab)
• Navelbine (vinorelbine)

Snippet

Sponsor: Vejle Hospital | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED